XLR Medical Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities.
Cash Flow
| Q1 2021 | 83.32K | -43.52K | 778.10K |
|---|
XLRM Cash Flow Statement (Q1 2021 – Q1 2021)
| Q1 2021 | |
|---|---|
Cash at beginning of period | 72.20K |
Operating activities | |
Net income | -1.56M |
| Adjustments to reconcile net income to cash generated by operating activities: | |
Depreciation and amortization | 96.10K |
Stock-based compensation expense | 0 |
| Deferred income tax benefit | 0 |
| Changes in operating assets and liabilities: | |
Accounts receivable, net | -17.41K |
Inventories | 13.14K |
Accounts payable | 212.87K |
Cash generated by operating activities | 83.32K |
Investing activities | |
Purchases Of Investments | 0 |
Investments In Property Plant And Equipment | -43.52K |
Acquisitions Net | 0 |
Cash generated by investing activities | -43.52K |
Financing activities | |
Common Stock Issued | 0 |
Payments for dividends | 0 |
Repurchases of common stock | 0 |
Repayments of term debt | -20K |
Cash used in financing activities | 778.10K |
Net Change In Cash | 817.90K |
Cash at end of period | 890.10K |
| Data source |